Sutro Biopharma Inc
STRO
Market Cap$314.91M
Close$
$5.81
68% upside
Current Fair Value
68% upsideUndervalued by 68% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $314.91 Million |
|---|---|
| Enterprise Value | $29.76 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.89 |
| Beta | 0.0 |
| Outstanding Shares | 81,794,334 |
| Avg 30 Day Volume | 801,726 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.74 |
|---|---|
| PEG | -16.8 |
| Price to Sales | 3.46 |
| Price to Book Ratio | 3.46 |
| Enterprise Value to Revenue | 0.19 |
| Enterprise Value to EBIT | -0.29 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.94 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sutro Biopharma Inc
CEO: William Newell